Home
NewsNewsINVO Fertility looks to acquire Family Beginnings to advance its national expansion and broaden innovative care access.
INVO Fertility, Inc., which is a healthcare fertility company that is focused on the establishment and acquisition as well as the operation of fertility clinics and also related businesses along with technologies, announced on November 28, 2025, its intent to go ahead and acquire Family Beginnings, P.C., which is a well-respected fertility clinic that serves patients throughout Indiana as well as the broader Midwest. The plan to acquire Family Beginnings goes on to mark the second acquisition by INVO after its purchase of Wisconsin Fertility Institute in 2023 and also reflects the multi-pronged strategic initiative of the company so as to build a countrywide network of fertility centers that are capable of reaching the underserved markets and also meeting the growing demand of patients.
According to the CEO of INVO, Steve Shum, Family Beginnings has long been recognized due to its exceptional standards when it comes to care, and they are indeed quite thrilled to welcome Dr. James Donahue as well as his talented team into the INVO family. From their earliest conversations, it was indeed very clear that they go on to share a common philosophy, which is centered on compassionate and patient-first treatment. Equally as exciting remains the fact that Dr. Donahue was an early adopter and still remains a very ardent advocate of their innovative INVOcell technology. Their intravaginal culture – IVC solution is well integrated in his practice and is one of the many treatment options that are offered to patients. Partnering with Dr. Donahue as well as the Family Beginnings team is a significant step in pursuit of their strategic growth push, and they look forward to supporting this continued success as they go on to expand their presence throughout the Midwest.
Family Beginnings, which was founded in the late 1990s, went on to serve thousands of patients throughout Indiana as well as surrounding states. Known due to its customized care model as well as pretty robust success rates, the clinic provides a full suite of reproductive services, which includes:
As per Family Beginnings’ James Donahue, M.D., HCLD, and founder, they are very excited to join forces with INVO Fertility and that their respective teams share a very deep commitment so as to help the individuals as well as their families attain their dreams of parenthood. Through partnering with INVO, they are surely going to be able to broaden their offerings, introduce a new and innovative set of treatment options, and make sure of even more patients benefiting from the high level of care that they have always provided. This partnership, he says, marks the start of an exciting new chapter when it comes to their clinic and patients.
Because of this acquisition, INVO plans to upgrade the Family Beginnings clinic by way of:
Shum says that this acquisition is certainly a natural fit with their mission to go ahead and make fertility care much more accessible and also patient-centered. According to him, strategic acquisitions such as this are a core component when it comes to their growth plan, since they enable them to speed up the expansion while at the same time integrating the proven teams along with clinical infrastructure. Having implemented a term sheet with Dr. Donahue more than a month ago, they are well in sync with completing the final agreements and also anticipate closing the transaction in the near future.
Notably, this acquisition remains subject to the completion of customary due diligence through INVO and the negotiation as well as entry into definitive purchase agreements between INVO and Family Beginnings. The definitive agreements are also anticipated to have in them the closing conditions, customary covenants, any needed regulatory approvals, indemnification provisions, and termination rights. There can also be no assurances that INVO is going to enter into a definitive agreement or even complete the acquisition for that matter.
A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.
Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.
In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.
Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.
British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.
Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.
National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.
